about
A key role for NF-κB transcription factor c-Rel in T-lymphocyte-differentiation and effector functionsProteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis.IKK-induced NF-κB1 p105 proteolysis is critical for B cell antibody responses to T cell-dependent antigen.The proteasome system in infection: impact of β5 and LMP7 on composition, maturation and quantity of active proteasome complexesrKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in SudanLack of microbiota reduces innate responses and enhances adaptive immunity against Listeria monocytogenes infection.Antigen receptor-mediated depletion of FOXP3 in induced regulatory T-lymphocytes via PTPN2 and FOXO1.The role of NF-κB activation during protection against Leishmania infection.Heterogeneity in the differentiation and function of CD8⁺ T cells.Association between activation of atypical NF-kappaB1 p105 signaling pathway and nuclear beta-catenin accumulation in colorectal carcinoma.Beyond epithelial to mesenchymal transition: a novel role for the transcription factor Snail in inflammation and wound healing.Prevention of colitis-associated cancer by selective targeting of immunoproteasome subunit LMP7.c-REL and IκBNS Govern Common and Independent Steps of Regulatory T Cell Development from Novel CD122-Expressing Pre-Precursors.Transcription factor c-Rel is indispensable for generation of thymic but not of peripheral Foxp3+ regulatory T cells.Expression of catalytic proteasome subunits in the gut of patients with Crohn's disease.IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.Functional heterogeneity of gut-resident regulatory T cells.Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis.Leprosy susceptibility-a matter of protein degradation? The role of proteasomes in infection and disease.c-Rel promotes type 1 and type 17 immune responses during Leishmania major infection.Transcription factor c-Rel plays a crucial role in driving anti-CD40-mediated innate colitis.Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease?NALP expression in Paneth cells provides a novel track in IBD signaling.Comparative expression analysis and characterization of 20S proteasomes in human intestinal tissues: The proteasome pattern as diagnostic tool for IBD patients.c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells.Regulation of the effector function of CD8 T cells by gut microbiota-derived metabolite butyrateThe short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytesImmunoproteasomes are essential for clearance of Listeria monocytogenes in nonlymphoid tissues but not for induction of bacteria-specific CD8+ T cellsTc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammationThe NF-κB transcription factor c-Rel controls host defense against Citrobacter rodentiumShort-chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells
P50
Q27026685-937E8AE7-7909-4A8E-BBF2-F9431AFF39D9Q33264524-67C1544C-D87E-4C31-BD0D-8D7E461841ADQ34230541-7B5D3754-96D8-469E-A817-4201E5D581D7Q34328313-93D48826-0219-4099-A1FC-52D1F229BDC8Q34855381-7D00DEF0-A7CE-47E0-A8DC-11034D3EDB67Q35124453-37EADF2E-BD98-4845-B9BA-FD4D07025F2CQ36250847-01B0A448-3D4B-4494-9F74-C66F0C4E55DCQ38035467-F78749A5-A2B1-4622-BE06-A0379DEE1C18Q38216200-FCCA4F8F-CC8A-4215-9A4B-0C971AFFDBD7Q39760242-AB4D3ACA-B163-4BF1-8149-6196AD971CF0Q39783556-BB5C7983-4E49-4A67-9513-2E466F3DA4EEQ40062442-69729366-8254-46E2-A21B-7B173E978610Q40157148-D5520C9C-59CA-4B1A-B1DF-76F6AA76C218Q41592849-AA945BB8-D32A-4ED7-BBD2-20C038641A7EQ41810371-105E5A95-A8A5-42C1-A074-ABDA6C0FF721Q42136819-2178407D-B1B2-44E2-8B57-477854168369Q42279415-9A0DA7C9-B48A-47D8-9ACC-4E99B741145DQ43004297-6F40FA5D-053A-4E7C-AE38-1A9042B616AFQ43419445-BA58E3C8-4FE7-4BB8-9C87-2A9915C44D35Q46125164-1C828B3A-A0F7-47AF-864D-4B7FC60226A4Q52874734-F66B67BB-A131-4D03-B475-5375E3E515F1Q52891216-6E662E04-A2E0-4BDA-89D6-970DA7BFA14FQ52904802-98377D1C-5536-44EF-B9D5-D70268DCE5D0Q52914124-A71A2008-D613-49A7-8380-0C5290305142Q54562195-9A816E9C-7BAB-4774-B9AD-FC676B55D422Q58695540-19B029F6-BB71-42D8-B84C-3182400DC92BQ61795872-2F9BE055-E895-4F6A-B2A3-40C56CE057B5Q79287481-21B0C02B-3395-4174-9806-0497D969997EQ85741340-02032F57-854C-4157-9464-3405426AE3EEQ91277038-9B54173B-CB5E-4FF5-A57F-039EFF25EAAAQ91755202-E58B163A-94B8-4EAF-8D73-C29E58A96132
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alexander Visekruna
@ast
Alexander Visekruna
@en
Alexander Visekruna
@es
type
label
Alexander Visekruna
@ast
Alexander Visekruna
@en
Alexander Visekruna
@es
prefLabel
Alexander Visekruna
@ast
Alexander Visekruna
@en
Alexander Visekruna
@es
P106
P21
P2798
P31
P496
0000-0002-5207-9545